Mary Lucus
Keine laufenden Positionen mehr
Karriereverlauf von Mary Lucus
Ehemalige bekannte Positionen von Mary Lucus
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| SELECTIS HEALTH, INC. | Comptroller/Controller/Auditor | 01.04.2021 | 05.04.2023 |
| Finanzdirektor/CFO | 04.03.2022 | 05.04.2023 | |
| Unternehmenssekretär | 31.10.2022 | 05.04.2023 | |
| NEUBASE THERAPEUTICS, INC. | Comptroller/Controller/Auditor | - | - |
Ausbildung von Mary Lucus
| San Diego State University | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 4 |
Operativ
| Comptroller/Controller/Auditor | 2 |
| Director of Finance/CFO | 1 |
| Corporate Secretary | 1 |
Sektoral
| Finance | 2 |
| Health Technology | 2 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SELECTIS HEALTH, INC. | Finance |
| Private Unternehmen | 1 |
|---|---|
NeuBase Therapeutics, Inc.
 NeuBase Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology NeuBase Therapeutics, Inc. is a biotechnology company, which engages in the development of drugs for patients with genetic neurological disorders. The firm’s therapies are built on a proprietary platform called PATrOL that encompasses a novel peptide-nucleic acid antisense oligonucleotide technology combined with novel delivery shuttles that overcome many of the hurdles to selective mutation engagement, repeat dosing, and systemic delivery of genetic medicines. The company was founded by Dietrich A. Stephan on August 4, 2009 and is headquartered in Pittsburgh, PA. | Health Technology |
- Börse
- Insiders
- Mary Lucus
- Erfahrung
